S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
S&P 500   4,989.32 (-0.44%)
DOW   38,028.74 (+0.67%)
QQQ   416.96 (-1.52%)
AAPL   165.03 (-1.20%)
MSFT   399.52 (-1.17%)
META   484.01 (-3.55%)
GOOGL   154.03 (-1.27%)
AMZN   174.96 (-2.38%)
TSLA   149.16 (-0.51%)
NVDA   804.06 (-5.04%)
AMD   149.40 (-3.66%)
NIO   3.83 (-4.25%)
BABA   68.85 (-0.04%)
T   16.36 (+0.18%)
F   12.09 (+0.25%)
MU   107.39 (-4.06%)
GE   149.19 (-2.45%)
CGC   8.09 (+3.32%)
DIS   112.13 (-0.27%)
AMC   3.24 (+10.96%)
PFE   25.81 (+1.65%)
PYPL   62.16 (+0.10%)
XOM   120.07 (+1.31%)
Free Trial
NASDAQ:AKER

Akers Biosciences (AKER) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free AKER Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$2.25
▼
$2.52
50-Day Range
$2.47
▼
$4.59
52-Week Range
$1.65
▼
$6.97
Volume
54,002 shs
Average Volume
769,876 shs
Market Capitalization
$41.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsHeadlinesSocial Media
AKER stock logo

About Akers Biosciences Stock (NASDAQ:AKER)

Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York.

AKER Stock News Headlines

April 16, 2024 | msn.com
Springfield Police Superintendent Akers looks to connect with youth
April 10, 2024 | msn.com
Lawrence Akers sworn-in as Springfield’s next police superintendent
April 19, 2024 | TradeSmith (Ad)
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
April 10, 2024 | msn.com
Oil spillage on Akers Way after bus crash closes road
March 25, 2024 | msn.com
Betsy Akers reveals $35M Tuxedo Park mansion as her priciest listing yet
March 21, 2024 | msn.com
Woman charged with causing death of teenager on Akers Way
March 13, 2024 | msn.com
Cam Akers Becomes A Free Agent
March 7, 2024 | msn.com
Rugby Almanack editor Clive Akers steps down after 30 years at rugby book of record
April 19, 2024 | TradeSmith (Ad)
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
February 6, 2024 | msn.com
Akers Mill reopens, Powers Island unit closed at Chattahoochee River park
January 23, 2024 | health.usnews.com
Jennifer C. Akers
January 17, 2024 | msn.com
Will the Vikings Bring Back Restricted Free Agent RB Cam Akers in 2024?
January 15, 2024 | msn.com
Deputy Chief Lawrence Akers to become next Springfield Police Superintendent
January 9, 2024 | msn.com
JB Akers appointed to West Virginia House of Delegates
December 11, 2023 | msn.com
Tom Akers, Lewis Knudsen to perform holiday show
November 16, 2023 | axios.com
Chloe Akers: Bringing politics back to the middle
November 12, 2023 | msn.com
Cam Akers fined more for 'taunting' than Falcons player was for vicious hit
November 11, 2023 | msn.com
The NFL fined Cam Akers on the week he tore his Achilles once again
November 9, 2023 | msn.com
When Is Cam Akers Coming Back? Fantasy Football Injury Return Update
November 8, 2023 | msn.com
Cam Akers Dynasty Value: What Is the Vikings RB’s Value Now After His Injury?
November 8, 2023 | msn.com
Vikings put Cam Akers on IR, sign QB Tanner Morgan to practice squad
November 8, 2023 | cbsnews.com
Vikings place RB Cam Akers on IR, re-sign QB Tanner Morgan to practice squad
November 6, 2023 | msn.com
Former Rams running back Cam Akers feared to have torn his Achilles Sunday vs. Falcons
November 6, 2023 | msn.com
Cam Akers injures Achilles, could be done for season
November 6, 2023 | msn.com
Los Angeles Rams Ex Cam Akers Out For Season With Torn Achilles - Injury Tracker
November 6, 2023 | msn.com
Former Rams RB Cam Akers tears Achilles for 2nd time in less than 3 years
November 6, 2023 | msn.com
Vikings lose RB Cam Akers for rest of season because of Achilles tendon rupture
See More Headlines
Receive AKER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akers Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2018
Today
4/19/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:AKER
CUSIP
N/A
CIK
1321834
Web
www.akersbio.com
Phone
856 848 8698
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-3,890,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-87.42%
Return on Assets
-73.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
9.22
Quick Ratio
9.22

Sales & Book Value

Annual Sales
$1.58 million
Price / Sales
26.56
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.38 per share
Price / Book
0.47

Miscellaneous

Outstanding Shares
16,653,000
Free Float
N/A
Market Cap
$41.96 million
Optionable
Not Optionable
Beta
0.30
7 Stocks to Buy And Hold Forever Cover
7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Christopher C. Schreiber (Age 56)
    CEO, Pres & Director
    Comp: $507.62k
  • Mr. Ian Rhodes (Age 48)
    Interim Chief Financial Officer
  • Mr. Gary M. Rauch (Age 65)
    VP of Fin. & Treasurer

Key Competitors

View All Competitors

AKER Stock Analysis - Frequently Asked Questions

How were Akers Biosciences' earnings last quarter?

Akers Biosciences, Inc. (NASDAQ:AKER) announced its earnings results on Thursday, November, 15th. The medical instruments supplier reported ($0.26) earnings per share for the quarter. The medical instruments supplier had revenue of $0.56 million for the quarter.

What is Thomas A. Nicolette's approval rating as Akers Biosciences' CEO?

3 employees have rated Akers Biosciences Chief Executive Officer Thomas A. Nicolette on Glassdoor.com. Thomas A. Nicolette has an approval rating of 64% among the company's employees.

What other stocks do shareholders of Akers Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akers Biosciences investors own include ImmunoGen (IMGN), Sorrento Therapeutics (SRNE), AVEO Pharmaceuticals (AVEO), Advanced Micro Devices (AMD), Aytu BioPharma (AYTU), Biopharmx (BPMX), Neovasc (NVCN), Micron Technology (MU), Vaxart (VXRT) and Anavex Life Sciences (AVXL).

This page (NASDAQ:AKER) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
SHOCKING Crypto Leak…
Crypto 101 Media
How Biden has already won 2024
Porter & Company
Urgent alert: open this for a huge profit potential
Timothy Sykes